Metabolic map and bioactivation of the anti-tumour drug noscapine.
about
The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical ApplicationsRational design, synthesis, and biological evaluation of third generation α-noscapine analogues as potent tubulin binding anti-cancer agentsMetabolic profiling of praziquantel enantiomers.Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine.Noscapine recirculates enterohepatically and induces self-clearance.Metabolic mapping of A3 adenosine receptor agonist MRS5980Emerging applications of metabolomics in studying chemopreventive phytochemicals.Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.In vivo effects of the pure aryl hydrocarbon receptor antagonist GNF-351 after oral administration are limited to the gastrointestinal tract.Revisiting the Metabolism and Bioactivation of Ketoconazole in Human and Mouse Using Liquid Chromatography-Mass Spectrometry-Based Metabolomics.LC-MS-based metabolomics: an update.Carbon-carbon bond cleavage and formation reactions in drug metabolism and the role of metabolic enzymes.Down-regulation of liver-intestine cadherin enhances noscapine-induced apoptosis in human colon cancer cells.Metabolic map of osthole and its effect on lipids.Molecular docking to understand the metabolic behavior of GNF-351 by CYP3A4 and its potential drug-drug interaction with ketoconazole.Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin GProbe substrate and enzyme source-dependent inhibition of UDP-glucuronosyltransferase (UGT) 1A9 by wogonin.Glucuronidation of the broad-spectrum antiviral drug arbidol by UGT isoforms.Comparison of inhibition capability of scutellarein and scutellarin towards important liver UDP-glucuronosyltransferase (UGT) isoforms.Identification and analysis of the reactive metabolites related to the hepatotoxicity of safrole.Acetylation serves as a protective group in noscapine biosynthesis in opium poppy.Metabolism profiling of amino-noscapine.Application of Metabolomics in the Study of Natural Products
P2860
Q26801133-E0F1E9EB-B5B3-44FF-B6AE-1F2981B9CB08Q28534566-B17E6259-EAD5-4E94-A654-BE543C7DC24EQ34208792-96A89CCD-22F5-4903-ABE6-0ACAE1E5CA3BQ35891741-26FA7CB9-C218-4504-BFB8-5281E6939989Q35893886-04AC9A90-98AA-4D10-9F04-F81D6F95EA0EQ36088970-61DFCED2-D724-41E0-A19D-4CB441749BE5Q37207769-E554EF77-FD7D-4DE3-BBF3-C4EE31CEAB84Q37325594-EB9D944F-4400-4AC3-92E4-67A7D4CFDDC9Q37665619-9D37B014-F11E-4137-9C0B-C9BD680521E1Q37729280-7AD7E496-0827-4279-9806-543BDB04F3C0Q38202881-3B731856-F5E2-4A2F-84A0-564975482753Q38590451-15A0BFB6-E140-4CDD-9CEA-F5A1FF67B257Q38700109-F089D311-EEB0-4A82-AAEC-0BF96D52D63EQ38911805-0BAE31BF-EDAB-453D-B7E3-09F2F8E4923BQ39205301-5DED40B6-AFA0-4924-9457-A54C5EB6E26BQ40782905-1F2F4A65-84C4-4DEE-95D9-CC726A2359C1Q42912104-DF5B7528-B04F-4AFA-864A-CF39C3B01AD5Q43452825-7C0EF9E0-AB50-4EB8-B49A-1B5451D5AEEDQ44653923-4115D5DD-D877-4D60-8941-8A22DC7D5917Q47693100-9E3A2B74-03B0-456E-822D-69740A3436A0Q48246803-925EF626-006B-4903-A197-B9904B476055Q53657031-7AEE3399-7E9C-4EF3-9F19-1ED3C6BF770FQ57173224-00E410B4-B217-4889-B405-18543CBAE7FA
P2860
Metabolic map and bioactivation of the anti-tumour drug noscapine.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Metabolic map and bioactivation of the anti-tumour drug noscapine.
@ast
Metabolic map and bioactivation of the anti-tumour drug noscapine.
@en
type
label
Metabolic map and bioactivation of the anti-tumour drug noscapine.
@ast
Metabolic map and bioactivation of the anti-tumour drug noscapine.
@en
prefLabel
Metabolic map and bioactivation of the anti-tumour drug noscapine.
@ast
Metabolic map and bioactivation of the anti-tumour drug noscapine.
@en
P2093
P2860
P1476
Metabolic map and bioactivation of the anti-tumour drug noscapine.
@en
P2093
Frank J Gonzalez
Kristopher W Krausz
Naoki Tanaka
Zhong-Ze Fang
P2860
P304
P356
10.1111/J.1476-5381.2012.02067.X
P407
P577
2012-11-01T00:00:00Z